C91.41
Hairy cell leukemia, in remission
Clinical Classification Guidelines
Medical Intelligence & Overview
Hairy cell leukemia (HCL) is a rare but slow-growing type of blood cancer that originates in the bone marrow and affects B lymphocytes, a type of white blood cell. When diagnosed as being in remission, it indicates that after treatment, signs and symptoms of the disease have significantly decreased or disappeared. This condition is classified under ICD-10 code C91.41, reflecting its specific status of remission. Despite being in remission, ongoing monitoring remains essential to ensure the disease does not return. This article provides a patient-friendly overview of hairy cell leukemia in remission, covering its causes, symptoms, diagnosis, and the typical course of treatment.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting B lymphocytes, especially the mutation in the BRAF gene, are linked to hairy cell leukemia. Environmental factors, though not well-established, may contribute to the development of the disease. Previous exposure to certain chemicals or radiation has been observed in some cases, but a direct cause-and-effect relationship has not been clearly established.
Key Symptoms: Persistent fatigue or weakness Unexplained weight loss Frequent infections due to reduced immune function Splenomegaly (enlarged spleen), which may cause discomfort or fullness in the left upper abdomen Easy bruising or bleeding owing to low platelet counts Night sweats Fever without apparent infection
Diagnostic & Treatment
Diagnosis Path: Diagnosing hairy cell leukemia involves a combination of laboratory tests, physical examinations, and medical history assessments. Key diagnostic steps include:
Treatment Protocols: While the goal of treatment is to induce remission, ongoing management is crucial because hairy cell leukemia is typically a chronic condition. Common treatment approaches include:
Clinical Advice & FAQs
Billing Guidance
Is C91.41 a billable ICD-10 code?
Yes, C91.41 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C91.41?
Clinical documentation must specify the nature of Hairy cell leukemia, in remission and any associated comorbidities for accurate reporting.
Cite this Clinical Reference